Interpace Biosciences, Inc.
USD1.63
-0.05 (-2.98%)
CEO
Thomas W. Burnell
IPO Date
1998-05-20
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
OTC
Country
US
Open
$1.71
Prev. Close
$1.68
Day Low
$1.63
Day High
$1.80
52W Low
$0.75
52W High
$2.40
Market Cap
$0.05B
Volume
0.02M
| 9,405,941 |
| $2.02 |
| 4 Feb 2026 | Ampersand 2018 Limited Partnership | 10 percent owner | C-Conversion | Disposed | 28,000 | $2.02 |
| 4 Feb 2026 | Ampersand 2018 Limited Partnership | 10 percent owner | C-Conversion | Acquired | 13,861,386 | $2.02 |
| 15 Oct 2024 | Ampersand 2018 Limited Partnership | 10 percent owner | A-Award | Acquired | 28,000 | $2.02 |
| 15 Oct 2024 | Ampersand 2018 Limited Partnership | 10 percent owner | D-Return | Acquired | 28,000 | $6.00 |
| 25 May 2021 | Burnell Thomas W. | director, officer: President & CEO | P-Purchase | Acquired | 10,855 | $8.68 |
| 12 Mar 2021 | Freeburg Thomas John | Chief Financial Officer | A-Award | Acquired | 50,000 | $0.00 |
| 12 Mar 2021 | Freeburg Thomas John | Chief Financial Officer | A-Award | Acquired | 50,000 | $6.00 |
| 1 Mar 2021 | Kamin Peter | 10 percent owner | P-Purchase | Acquired | 16,360 | $3.08 |